NPPB and hydrops fetalis: The discrepancies between those findings and ours may be explained by differences in trial design: (i) the presence of a run-in period in PARADIGM-HF and PARAGON-HF; (ii) the timing of NT-proBNP measurement at screening rather than at randomization; and (iii) the use of an active comparator rather than a placebo.